Announce Date | 04/29/2025 |
EPS Normalized Actual | $0.4 (Beat by $0.22) |
EPS GAAP Actual | $0.4 (Beat by $0.22) |
Revenue Actual | $1.567B |
Revenue Surprise | Beat by $1567M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $0.69339 |
EPS GAAP Estimate | $0.69339 |
Revenue Estimate | $1.897857075B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 2.52 | 6.22 | 2.46318 | 2.58597 | 1 |
Dec 2026 | 2.965 | 5.29 | 2.85 | 3.08 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.31 | 0.31 | 1.567B | -1.66% | 1567M |
FQ4 2024 (Dec 2024) | -1 | -1 | 1.529B | -7.33% | 1529M |
FQ3 2024 (Sep 2024) | 0.88 | 0.88 | 1.68B | -3.75% | 1680M |
FQ2 2024 (Jun 2024) | 0.94 | 0.94 | 1.729B | -9.31% | 1729M |
FQ1 2024 (Mar 2024) | 1.02 | 1.02 | 1.593B | -14.94% | 1593M |
FQ4 2023 (Dec 2023) | -3.05 | -3.05 | 1.641B | -3.17% | 1641M |
FQ3 2023 (Sep 2023) | 0.7 | 0.7 | 1.743B | 2.87% | 1743M |
FQ2 2023 (Jun 2023) | 1.26 | 1.26 | 1.89B | 5.93% | 1890M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
0.69339
Consensus Revenue Estimates
1.897857075B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.55807 | -- | 0.55274 | 0.56162 | 1 |
FQ3 2027 (Sep 2027) | 0.65548 | -- | 0.64922 | 0.65965 | 1 |
FQ2 2027 (Jun 2027) | 0.67555 | -- | 0.6691 | 0.67984 | 1 |
FQ1 2027 (Mar 2027) | 0.56329 | -- | 0.55791 | 0.56687 | 1 |
FQ4 2026 (Oct 2026) | 1.08434 | -- | 1.01558 | 1.14174 | 1 |
FQ3 2026 (Jul 2026) | 0.99865 | -- | 0.93533 | 1.05151 | 1 |
FQ2 2026 (Jun 2026) | 0.99865 | -- | 0.96559 | 1.04581 | 1 |
FQ1 2026 (Mar 2026) | 0.70749 | 56.18 | 0.68407 | 0.7409 | 1 |
FQ4 2025 (Oct 2025) | 0.80613 | 224.05 | 0.75501 | 0.8488 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.5B | -- | 1.49B | 1.5B | 2 |
FQ3 2027 (Sep 2027) | 1.64B | -- | 1.63B | 1.65B | 2 |
FQ2 2027 (Jun 2027) | 1.69B | -- | 1.67B | 1.69B | 2 |
FQ1 2027 (Mar 2027) | 1.55B | -- | 1.54B | 1.56B | 2 |
FQ4 2026 (Oct 2026) | 1.94B | -- | 1.84B | 2.02B | 2 |
FQ3 2026 (Jul 2026) | 2.04B | -- | 1.95B | 2.13B | 2 |
FQ2 2026 (Jun 2026) | 2.04B | -- | 1.99B | 2.12B | 2 |
FQ1 2026 (Mar 2026) | 1.87B | 16 | 1.82B | 1.93B | 2 |
FQ4 2025 (Oct 2025) | 1.91B | 20.11 | 1.82B | 1.99B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.31 | 0.31 | 100% | |
FQ4 2024 (Dec 2024) | -1 | -1 | 100% | |
FQ3 2024 (Sep 2024) | 0.88 | 0.88 | 100% | |
FQ2 2024 (Jun 2024) | 0.94 | 0.94 | 100% | |
FQ1 2024 (Mar 2024) | 1.02 | 1.02 | 100% | |
FQ4 2023 (Dec 2023) | -3.05 | -3.05 | 100% | |
FQ3 2023 (Sep 2023) | 0.7 | 0.7 | 100% | |
FQ2 2023 (Jun 2023) | 1.26 | 1.26 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $1.57B | $1567M | 100% |
FQ4 2024 (Dec 2024) | $0B | $1.53B | $1529M | 100% |
FQ3 2024 (Sep 2024) | $0B | $1.68B | $1680M | 100% |
FQ2 2024 (Jun 2024) | $0B | $1.73B | $1729M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.59B | $1593M | 100% |
FQ4 2023 (Dec 2023) | $0B | $1.64B | $1641M | 100% |
FQ3 2023 (Sep 2023) | $0B | $1.74B | $1743M | 100% |
FQ2 2023 (Jun 2023) | $0B | $1.89B | $1890M | 100% |